XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 82 filers reported holding XENON PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $44,000 | -90.8% | 2,365 | -91.1% | 0.00% | -100.0% |
Q1 2021 | $476,000 | -60.1% | 26,653 | -65.5% | 0.00% | -60.0% |
Q4 2020 | $1,192,000 | +30.3% | 77,358 | -6.5% | 0.01% | +25.0% |
Q3 2020 | $915,000 | +20.1% | 82,717 | +35.8% | 0.00% | +33.3% |
Q2 2020 | $762,000 | +1090.6% | 60,928 | +971.9% | 0.00% | – |
Q1 2020 | $64,000 | -25.6% | 5,684 | -45.7% | 0.00% | – |
Q3 2015 | $86,000 | -66.3% | 10,474 | -52.7% | 0.00% | -100.0% |
Q2 2015 | $255,000 | +292.3% | 22,126 | +468.9% | 0.00% | – |
Q1 2015 | $65,000 | -8.5% | 3,889 | +8.6% | 0.00% | – |
Q4 2014 | $71,000 | – | 3,581 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |